Admission Date:  [**2105-8-10**]              Discharge Date:   [**2105-8-14**]  Date of Birth:  [**2026-6-16**]             Sex:   M  Service: SURGERY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 473**] Chief Complaint: Melena  Major Surgical or Invasive Procedure: None   History of Present Illness: 79M s/p transduodenal resection ampullary mass (pathology benign) w/reimplantation of pancreatic and biliary ducts on [**2105-7-28**] presents at clinic outpatient visit with fatigue and tarry well-formed stools (2 days' duration) and a hematocrit of 20.3.
Labs were drawn after the visit: Hematocrit was 20.3, down from 28.5 on [**8-3**].
WBC was 12.7, up from 6.4 on [**8-3**].
Physical Exam: Upon Discharge: Vitals: 98.3, 81, 137/44, 18, 100% RA GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, nondistended, nontender, no rebound or guarding, normoactive bowel sounds, no palpable masses.
Ext: LE warm and well perfused   Pertinent Results: [**2105-8-13**] 01:09PM BLOOD Hct-30.2* [**2105-8-14**] 05:00AM BLOOD WBC-10.2 RBC-3.45* Hgb-10.0* Hct-30.6* MCV-89 MCH-28.9 MCHC-32.5 RDW-16.3* Plt Ct-308 [**2105-8-14**] 05:00AM BLOOD Glucose-102* UreaN-17 Creat-1.0 Na-133 K-3.8 Cl-102 HCO3-25 AnGap-10 [**2105-8-13**] 02:08AM BLOOD Amylase-240* [**2105-8-14**] 05:00AM BLOOD Calcium-7.5* Phos-2.4* Mg-2.0 [**2105-8-12**] 06:05AM BLOOD Type-ART pH-7.47*  [**2105-8-10**] CT ABD: IMPRESSION: 1.
Intraperitoneal lesion adjacent to the third portion of the duodenum represents an intraperitoneal hematoma in the setting of recent surgical procedure and hematocrit drop.
Correlation with amylase and lipase is recommended.
Brief Hospital Course: The patient s/p transduodenal ampullary mass resection [**7-28**] was readmitted to the HPB Surgical Service from clinic with HCT 20.3 and complains of melena at home.
Abdominal CT scan revealed intraperitoneal hematoma and focal pancreatitis.
The patient was transferred on the floor NPO with IVF, he was transfused with one unit of pRBC, patient's [**Month/Year (2) **] and Aspirin was held.
Post transfusion HCT was 21.6 and patient received 2 more units of pRBC.
The patient's HCT was 21.0 after second transfusion and patient was transferred in ICU for closer observation.
Patient's HCT increased to 31.6 and remained stable prior discharge.
Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored.
OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain 7.
Upper GI bleed   Discharge Condition: Mental Status: Clear and coherent.
